Stay updated on Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.

Latest updates to the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page
- Check7 days agoChange DetectedDifference0.4%
- Check14 days agoChange DetectedDifference0.6%
- Check22 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.9%
- Check29 days agoChange DetectedDifference0.7%
- Check36 days agoChange DetectedThe webpage has undergone significant updates, including the removal of detailed descriptions of a clinical study involving galinpepimut-S and pembrolizumab, while adding new collaborators and a revision number. The focus has shifted to a more concise presentation of the study's objectives and collaborators.SummaryDifference48%
- Check43 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.2%
Stay in the know with updates to Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Galinpepimut-S and Pembrolizumab Combo in Advanced Cancers Clinical Trial page.